Evaluation of anti-Candida potential of geranium oil constituents against clinical isolates of Candida albicans differentially sensitive to fluconazole: inhibition of growth, dimorphism and sensitization.
about
Chemical Composition and Anti-Candidiasis Mediated Wound Healing Property of Cymbopogon nardus Essential Oil on Chronic Diabetic WoundsRose geranium essential oil as a source of new and safe anti-inflammatory drugsNew Claims for Wild Carrot (Daucus carota subsp. carota) Essential Oil.The Sensitivity of Endodontic Enterococcus spp. Strains to Geranium Essential Oil.Antifungal mechanism of the combination of Cinnamomum verum and Pelargonium graveolens essential oils with fluconazole against pathogenic Candida strains.Investigating the antifungal activity and mechanism(s) of geraniol against Candida albicans strains.Small molecules inhibit growth, viability and ergosterol biosynthesis in Candida albicans.Synergism Effect of the Essential Oil from Ocimum basilicum var. Maria Bonita and Its Major Components with Fluconazole and Its Influence on Ergosterol Biosynthesis.Antifungal Activity of Commercial Essential Oils and Biocides against Candida Albicans.Effects of clary sage oil and its main components, linalool and linalyl acetate, on the plasma membrane of Candida albicans: an in vivo EPR study.Microenvironment Responsive Modulations in the Fatty Acid Content, Cell Surface Hydrophobicity, and Adhesion of Candida albicans Cells.
P2860
Q28828280-F97B1B73-C900-4480-A2B0-03FE9A428215Q37221725-0DDCBE6A-B708-420C-B2DC-1CCA3BFB0F97Q38661806-EC3DC27E-865A-4D55-88CF-953D62CAAEB7Q38809145-03AA6C02-6218-477A-A3CC-2AAB6FB9D573Q40110374-334ADA8A-AB37-4650-88CE-970D882FBF6EQ41614656-056D7CF5-F4DA-48A4-8F00-8A5DD2E0AE0FQ41876856-0EE164A2-330E-420A-959B-F315D23D445FQ42778525-3C436D32-27EC-48F2-8BCC-7AD26CFCA52EQ48166226-BEFFA541-4368-4DDF-9626-E14A4E557738Q51104508-97141EBE-7EC2-4AE8-BF94-2831BB52DD63Q55435395-6138713E-5BFF-43AA-AFFC-7779970ECCAC
P2860
Evaluation of anti-Candida potential of geranium oil constituents against clinical isolates of Candida albicans differentially sensitive to fluconazole: inhibition of growth, dimorphism and sensitization.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Evaluation of anti-Candida pot ...... dimorphism and sensitization.
@en
Evaluation of anti-Candida pot ...... dimorphism and sensitization.
@nl
type
label
Evaluation of anti-Candida pot ...... dimorphism and sensitization.
@en
Evaluation of anti-Candida pot ...... dimorphism and sensitization.
@nl
prefLabel
Evaluation of anti-Candida pot ...... dimorphism and sensitization.
@en
Evaluation of anti-Candida pot ...... dimorphism and sensitization.
@nl
P2093
P2860
P1433
P1476
Evaluation of anti-Candida pot ...... dimorphism and sensitization.
@en
P2093
Archana D Thakre
Gajanan B Zore
S Mohan Karuppayil
P2860
P304
P356
10.1111/J.1439-0507.2009.01852.X
P577
2010-03-11T00:00:00Z